National survey investigating hallucinogenic trends (NSIHT): data on selected drugs of interest
Active Awarded
- Contract number
- 75F40126F19004
- Awardee
-
Denver Health And Hospital Authority UEI MMT4LGM4H9Z5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $309,340
Award facts
- Contract value 100% obligated
- $309,340.00 Current and potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ15 General Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a $309,340 firm fixed-price delivery order to Denver Health and Hospital Authority for the National Survey Investigating Hallucinogenic Trends (NSIHT): Data on Selected Drugs of Interest. The work is being performed in Silver Spring, Maryland, with an ultimate completion date of December 16, 2026. This delivery order, which carries no set-aside designation, is issued under Denver Health's existing $10 million FDA data resources contract for post-marketing pharmaceutical surveillance—a multiple-award indefinite delivery vehicle that enables the organization to provide data analytics and survey research services supporting the FDA's drug safety monitoring initiatives.
Denver Health, a 555-bed academic healthcare system based in Denver, Colorado, brings substantial experience in federal health research and data collection to this engagement. As a significant federal contractor and grantee since 2001, Denver Health has conducted similar pharmaceutical surveillance and drug use survey work for the FDA and other federal agencies including the Substance Abuse and Mental Health Services Administration (SAMHSA). The organization's established capabilities in collecting data on drug use patterns and pharmaceutical prevalence through online panel surveys and specialized research methodologies position it to effectively deliver the hallucinogenic drug trend data sought by the FDA.
Quick answers
Who was awarded contract 75F40126F19004?
75F40126F19004 was awarded to Denver Health And Hospital Authority by Food and Drug Administration (Department of Health and Human Services) on December 19, 2025.
How much is contract 75F40126F19004 worth?
The government has obligated $309,340 on 75F40126F19004.
Is contract 75F40126F19004 an order under another contract?
Yes. 75F40126F19004 is a delivery order under 75F40121D00033, an indefinite delivery contract.
Was contract 75F40126F19004 competed?
The extent of competition for 75F40126F19004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award